| Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state. | |
| | |
MedLine Citation:
|
PMID: 19898283 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The primary objective of treatment in patients with chronic coronary artery disease (CAD) and stable angina is relief of symptoms and improvement of clinical outcome. The American College of Cardiology/American Heart Association guidelines have emphasized the role of evidence-based therapies. There have been regular updates of the guidelines, with an effort to include the latest data in the recommendations. Since the 2002 guidelines were published, there have been several pivotal studies that have provided strong support for the role of aggressive and optimal medical therapy in improving clinical outcomes in patients with chronic CAD. Recent data from 2 landmark studies have emphasized that optimal medical therapy is as effective as myocardial revascularization with percutaneous coronary intervention or coronary artery bypass grafting in reducing risk of adverse clinical outcomes. The 2009-2010 guidelines will likely incorporate the findings of these studies and accordingly modify the recommendations for treatment of patients with chronic CAD and stable angina. |
| | |
Authors:
|
Prakash C Deedwania; Enrique V Carbajal |
Related Documents
:
|
9223353 - New insights into the pathogenesis and prevention of acute coronary syndromes. 10941543 - Clinical and nonclinical correlates of racial and ethnic differences in recommendation ... 3227323 - Long-term follow-up of right ventricular function after mustard operation for transposi... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Reviews in cardiovascular medicine Volume: 10 Suppl 1 ISSN: 1530-6550 ISO Abbreviation: Rev Cardiovasc Med Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-11-09 Completed Date: 2010-11-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960007 Medline TA: Rev Cardiovasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: S11-20 Citation Subset: IM |
Affiliation:
|
Cardiology Division, Department of Medicine, VA Central California Health Care System/UCSF Program, Fresno, CA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
American Heart Association Angina Pectoris / diagnosis, etiology, therapy* Cardiovascular Agents / therapeutic use* Chronic Disease Coronary Artery Disease / complications, diagnosis, therapy* Drug Therapy, Combination Evidence-Based Medicine Humans Myocardial Revascularization* Practice Guidelines as Topic Risk Assessment Risk Factors Treatment Outcome United States |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ischemia is the critical determinant of revascularization benefit: an interventionalist's perspectiv...
Next Document: Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options f...